Pages that link to "Q73317565"
Jump to navigation
Jump to search
The following pages link to Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders (Q73317565):
Displaying 22 items.
- Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor (Q21260342) (← links)
- Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression (Q24793805) (← links)
- Zellweger spectrum disorders: clinical overview and management approach (Q26775566) (← links)
- Restoring the DHA levels in the brains of Zellweger patients (Q30657539) (← links)
- Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients (Q33563175) (← links)
- Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival (Q33911514) (← links)
- Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder (Q34065537) (← links)
- Docosahexaenoic acid accumulation in the prenatal brain: prooxidant and antioxidant features (Q34322467) (← links)
- Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue (Q34322479) (← links)
- Docosahexaenoic acid: membrane properties of a unique fatty acid (Q34542831) (← links)
- What is the role of alpha-linolenic acid for mammals? (Q35078194) (← links)
- In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism (Q35575661) (← links)
- A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial (Q36810081) (← links)
- Biochemical and biological functions of docosahexaenoic acid in the nervous system: modulation by ethanol (Q36839901) (← links)
- Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis (Q36965015) (← links)
- Neurological benefits of omega-3 fatty acids (Q37187559) (← links)
- Mechanisms of disease: Inborn errors of bile acid synthesis (Q37199631) (← links)
- Omega 3 fatty acids and inborn errors of metabolism (Q38010552) (← links)
- Inhibition of peroxisomal functions due to oxidative imbalance induced by mistargeting of catalase to cytoplasm is restored by vitamin E treatment in skin fibroblasts from Zellweger syndrome-like patients. (Q40482584) (← links)
- Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid (Q42215577) (← links)
- The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects (Q48714638) (← links)
- Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat (Q83206221) (← links)